Noteworthily, autoimmune diseases are suggested to show a trajectory where CD3+/CD56+ natural killer-T cell (NKT cell) levels are elevated in the initial stage of the disease process as a first-line cellular innate response but NKT cells are depleted in later stages [8]. Here, NCAM1 is linked to autoimmune disease.